Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,062,848; Remeron
The Patent and Trademark Office has issued a certificate under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 4,062,848 that claims the human drug product known as Remeron.
- Task
- Read the news
- Patent or trademark
- both
- Legacy system
- —
- Current entry point
- www.federalregister.gov/documents/1994/12/13/94-30545/grant-of-certificate-of-interim-extension-of-the-term-of-us-patent-no-4062848-remeron (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- No fee mention in title or summary )
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 1994-12-13
- Document type
- Uncategorized Document
- Source
- USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)
Everything in the same category
Read the news (all 1988) · both (all 2333)
Related entry points
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,048,306; Dynabac
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,066,772; Motilium
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,197,297; CORLOPAMRegister
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,005,196; Olestra
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. Re. 34,617 of U.S. Patent No. 4,005,196; Olestra
- Grant of Interim Extension of the Term of U.S. Patent No. 5,496,801; Recombinant Human Parathyroid Hormone
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,229,449; roboxetine mesylate
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,229,449: Roboxetine Mesylate
- Grant of Interim Extension of the Term of U.S. Patent No. 4,229,449; Roboxetine Mesylate
- Grant of Interim Extension of the Term of U.S. Patent No. 4,567,264; Ranolazine
- Grant of Interim Extension of the Term of U.S. Patent No. 4,585,597; ANTHÉLIOS® SP Topical Cream (Mexoryl® SX (ecamsule))
- Grant of Interim Extension of the Term of U.S. Patent No. 4,591,585; Atamestane
- Grant of Interim Extension of the Term of U.S. Patent No. 4,600,706; Natamycin
- Grant of Second Interim Extension of the Term of U.S. Patent No. 4,585,597; Ecamsule
- Grant of Interim Extension of the Term of U.S. Patent No. 4,567,264; Ranolazine
- Grant of Interim Extension of the Term of U.S. Patent No. 4,603,123; Piroxicam Betadex